News > DCGI approves Biological E`s phase 2 and 3 trials of COVID vaccine on children
DCGI approves Biological E`s phase 2 and 3 trials of COVID vaccine on children
Dais Newsfeed | 02/09/2021 03:16 PM | Click to read full article
The Drug Controller General of India (DCGI) has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots called Corbevax on children.
The trial will be on children between 5 and 18 years of age with certain conditions. The trial will be conducted in ten locations across the country.
